Table 1 Characteristics of included studies on association between frailty and clinical outcomes
Study | Study type | Location | Type of ACS | Frailty measure | Age | Sample Size (n) | No.of Males | Prevalence (frailty,%) | Prevalence (pre-frailty) | Follow-up (mo) |
|---|---|---|---|---|---|---|---|---|---|---|
Ekerstad 2011 | Prospective | Sweden | NSTEMI | CSHA-CFS | ≥ 75 | 307 | 257 | 48.50% | N/A | 1 |
Ekerstad 2014 | Prospective | Sweden | NSTEMI | CSHA-CFS | ≥ 75 | 307 | 257 | 48.50% | N/A | 12 |
Graham 2013 | Prospective | Canada | ACS | EFS | ≥ 65 | 183 | 123 | 30.05% | 35.50% | 12 |
Sanchis 2014 | Prospective | Spain | ACS | Green scores | ≥ 65 | 342 | 196 | 48.00% | N/A | Mean 25 (31–72) |
Sanchis 2018 | Prospective | Spain | ACS | Green scores | ≥ 65 | 342 | 196 | 48.00% | N/A | Mean 56.4 |
Kang 2015 | Prospective | China | ACS | CSHA-CFS | ≥ 65 | 352 | 203 | 43.20% | N/A | 6.3 |
Sujino 2015 | Retrospective | Japan | STEMI | CSHA-CFS | ≥ 85 | 62 | 36 | 35.50% | N/A | in-hospital |
White 2016 | Prospective | Multicentre | UA/NSTEMI | Fried Frailty score | ≥ 65 | 4996 | 2691 | 4.70% | 23.00% | Mean 17.1 (10.4–24.4) |
Alonso 2016 a | Prospective | Spain | type 1 MI | SHARE-FI | ≥75 | 190 | 115 | 37.90% | 28.40% | 1 |
Alonso 2016 b | Prospective | Spain | type 1 MI | SHARE-FI | ≥75 | 202 | 121 | 35.10% | 36.60% | in-hospital |
Alonso 2017 | Prospective | Spain | type 1 MI | SHARE-FI | ≥75 | 234 | 139 | 40.20% | 28.2% | 6 |
Alonso 2018 | Prospective | Spain | type 1 MI | SHARE-FI | ≥75 | 285 | 171 | 38.20% | 29.80% | 12 |
Kirill 2017 | Prospective | Russia | ACS | Computer program of geriatric examination | elderly Senile | 633 | N/A | 35.50% | N/A | 12 |
Blanco 2017 | Prospective | France | ACS | EFS | ≥ 80 | 236 | N/A | 20.8% | 28.8% | Mean 15.7 |
Alegre 2018 | Prospective | Spain | NSTEMI | FRAIL scale | ≥ 80 | 532 | 328 | 27.30% | 38.50% | 6 |